Genetic control of estrogen action in the rat: Mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross

Mammalian Genome

Volumn 18, Issue 9, 2007, Pages 657-669

  Shull, James D ^a,b   Lachel, Cynthia M ^a   Murrin, Clare R ^a   Pennington, Karen L ^a   Schaffer, Beverly S ^a   Strecker, Tracy E ^a,b   Gould, Karen A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUGUST COPENHAGEN IRISH RAT; AUTOPSY; BREAST CANCER; BROWN NORWAY RAT; CANCER SUSCEPTIBILITY; CHROMOSOME 4; CONTROLLED STUDY; ESTROGEN ACTIVITY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC REGULATION; HYPERPLASIA; HYPOPHYSIS DISEASE; HYPOPHYSIS TUMOR; MALE; NONHUMAN; PROGENY; QUANTITATIVE TRAIT LOCUS; RAT;

ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; ESTRADIOL; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HYPERPLASIA; LACTOTROPHS; MALE; PITUITARY DISEASES; PITUITARY GLAND, ANTERIOR; QUANTITATIVE TRAIT LOCI; RATS; RATS, INBRED ACI; RATS, INBRED BN;

RATTUS; RATTUS NORVEGICUS;

EID: 35048824786     PISSN: 09388990     EISSN: 14321777     Source Type: Journal    
DOI: 10.1007/s00335-007-9052-2     Document Type: Article

References (58)

1. Aoki MP, Orgnero E, Aoki A, Maldonado CA (2003) Apoptotic cell death of oestrogen activated lactotrophs induced by tamoxifen. Tissue Cell 35:143-152
2. Blankenstein MA, Broerse JJ, van Zwieten MJ, Van Der Molen HJ (1984) Prolactin concentration in plasma and susceptibility to mammary tumors in female rats from different strains treated chronically with estradiol-17β. Breast Cancer Res Treat 4:137-141
3. Churchill GA, Doerge RW (1994) Empirical threshold values for quantitative trait mapping. Genetics 138:963-971
4. Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocrine Rev 24:1-27
5. Clifton KH, Furth J (1961) Changes in hormone sensitivity of pituitary mammotropes during progression from normal to autonomous. Cancer Res 21:913-920
6. Couse JF, Korach KS (1999) Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Rev 20:358-417
7. Doerge RW (2002) Mapping and analysis of quantitative trait loci in experimental populations. Nat Rev Genet 3:43-52
8. Falconer DS, MacKay TFC (1996) Introduction to Quantitative Genetics, 4th edn. (Harlow, UK: Longman Group)
9. Goffin V, Binart N, Touraine P, Kelly PA (2002) Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47-67
10. Gould KA, Shull JD, Gorski J (2000) DES action in the thymus: inhibition of cell proliferation and genetic variation. Mol Cell Endocrinol 170:31-39
11. Gould KA, Tochacek M, Schaffer BS, Reindl TM, Murrin CR, et al. (2004) Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18. Genetics 168:2113-2125
12. Gould KA, Pandey J, Lachel CM, Murrin CR, Flood LA, et al. (2005) Genetic mapping of Eutr1, a locus controlling E2-induced pyometritis in the Brown Norway rat, to RNO5. Mamm Genome 16:854-864
13. Gould KA, Strecker TE, Hansen KK, Bynoté KK, Peterson KA, et al. (2006) Genetic mapping of loci controlling sensitivity to diethylstilbestrol- induced thymic atrophy in the Brown Norway rat. Mamm Genome 17:451-464
14. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
15. Harris J, Stanford PM, Oakes SR, Ormandy CJ (2004) Prolactin and the prolactin receptor: new targets of an old hormone. Ann Med 36:414-425
16. Harvell DME, Strecker TE, Tochacek M, Xie B, Pennington KL, et al. (2000) Rat strain specific actions of 17β-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers. Proc Natl Acad Sci USA 97:2779-2784
17. Harvell DME, Strecker TE, Xie B, Buckles LK, Tochacek M, et al. (2001) Diet-gene interactions in estrogen-induced mammary carcinogenesis in the ACI rat. J Nutr 131:3087S-3091S
18. Harvell DME, Strecker TE, Xie B, Pennington KL, McComb RD, et al. (2002) Dietary energy restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. Carcinogenesis 23:161-169
19. Harvell DM, Buckles LK, Gould KA, Pennington KL, McComb RD, et al. (2003) Rat strain specific attenuation of estrogen action in the anterior pituitary gland by dietary energy restriction. Endocrine 21:175-183
20. Heaney AP, Fernando M, Melmed S (2002) Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 109:277-283
21. Holtzman S, Stone JP, Shellabarger CJ (1979) Influence of diethylstilbestrol treatment on prolactin cells of female ACI and Sprague-Dawley rats. Cancer Res 39:779-784
22. Korach KS, Emmen JM, Walker VR, Hewitt SC, Yates M, et al. (2003) Update on animal models developed for analyses of estrogen receptor biological activity. J Steroid Biochem Mol Biol 86:387-391
23. Lyle SF, Wright K, Collins DC (1984) Comparative effects of tamoxifen and bromocriptine on prolactin and pituitary weight in estradiol-treated male rats. Cancer 53:1473-1477
24. Manly KF, Olson JM (1999) Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 10:327-334
25. Manly KF, Cudmore RH Jr, Meer JM (2001) Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 12:930-932
26. Meyer RK, Clifton KH (1956) Effect of diethylstilbestrol-induced tumorigenesis on the secretory activity of the rat anterior pituitary gland. Endocrinology 58:686-693
27. Pandey J, Wendell DL (2006) Angiogenesis and capillary maturation phenotypes associated with the Edpm3 locus on rat chromosome 3. Mamm Genome 17:49-57
28. Pandey J, Bannout A, Wendell DL (2004) The Edpm5 locus prevents the 'angiogenic switch' in an estrogen-induced rat pituitary tumor. Carcinogenesis 25:1829-1838
29. Pandey J, Gould KA, McComb RD, Shull JD, Wendell DL (2005) Localization of Eutr2, a locus controlling susceptibility to DES-induced uterine inflammation and pyometritis, to RNO5 using a congenic rat strain. Mamm Genome 16:865-872
30. Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, et al. (2003) Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene 22:4664-4674
31. Schaffer BS, Lachel CM, Pennington KL, Murrin CR, Strecker TE, et al. (2006) Genetic bases of estrogen-induced tumorigenesis in the rat: mapping of loci controlling susceptibility to mammary cancer in a Brown Norway x ACI intercross. Cancer Res 66:7793-7800
32. Sclafani RV, Wendell DL (2001) Suppression of estrogen-dependent MMP-9 expression by Edpm5, a genetic locus for pituitary tumor growth in rat. Mol Cell Endocrinol 176:145-153
33. Segaloff A, Dunning WF (1945) The effect of strain, estrogen, and dosage on the reaction of the rat's pituitary and adrenal to estrogenic stimulation. Endocrinology 36:238-240
34. Shull JD (2002) Hormonal Carcinogenesis. In: Bertino JR (ed), Encyclopedia of Cancer vol 2 (San Diego, CA: Academic Press), pp 417-428
35. Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL (1997) Ovary intact, but not ovariectomized female ACI rats treated with 17b-estradiol rapidly develop mammary carcinoma. Carcinogenesis 18:1595-1601
36. Shull JD, Birt DF, McComb RD, Spady TJ, Pennington KL, et al. (1998) Estrogen induction of prolactin-producing pituitary tumors in the Fischer 344 rat: modulation by dietary energy, but not protein, consumption. Mol Carcinog 23:96-105
37. Shull JD, Pennington KL, Reindl TM, Snyder MC, Strecker TE, et al. (2001) Susceptibility to estrogen-induced mammary cancer segregates as an incompletely dominant phenotype in reciprocal crosses between the ACI and Copenhagen rat strains. Endocrinology 142:5124-5130
38. Spady TJ, Harvell DME, Snyder MC, Pennington KL, McComb RD, et al. (1998a) Estrogen-induced tumorigenesis in the Copenhagen rat: disparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett 124:95-103
39. Spady TJ, Lemus-Wilson AM, Pennington KL, Blackwood DJ, Paschall TM, et al. (1998b) Dietary energy restriction abolishes development of prolactin-producing pituitary tumors in Fischer 344 rats treated with 17β-estradiol. Mol Carcinog 23:86-95
40. Spady TJ, Harvell DME, Lemus-Wilson A, Strecker TE, Pennington KL, et al. (1999a) Modulation of estrogen action in the pituitary and mammary glands by dietary energy consumption. J Nutr 129:587S-590S
41. Spady TJ, McComb RD, Shull JD (1999b) Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland. Endocrine 11:217-233
42. Spady TJ, Pennington KL, McComb RD, Birt DF, Shull JD (1999c) Estrogen induced pituitary tumor development in the ACI rat is not inhibited by dietary energy restriction. Mol Carcinog 26:239-254
43. Spady TJ, Pennington KL, McComb RD, Shull JD (1999d) Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant Mendelian inheritance of the ACI phenotype. Endocrinology 140:2828-2835
44. Stone JP, Holtzman S, Shellabarger CJ (1979) Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACI and Sprague-Dawley rats. Cancer Res 39:773-778
45. Strecker TE, Spady TJ, Schaffer BS, Gould KA, Kaufman AE, et al. (2005) Genetic bases of estrogen-induced pituitary tumorigenesis: identification of genetic loci determining estrogen-induced pituitary growth in reciprocal crosses between the ACI and Copenhagen rat strains. Genetics 169:2189-2197
46. Tachibana M, Lu L, Hiai H, Tamura A, Matsushima Y, et al. (2006) Quantitative trait loci determining weight reduction of testes and pituitary by diethylstilbesterol in LEXF and FXLE recombinant inbred strain rats. Exp Anim 55:91-95
47. Tochacek M, Vander Woude EA, Spady TJ, Harvell DME, Snyder MC, et al. (2001) The ACI rat as a genetically defined animal model for the study of estrogen induced mammary cancers. In: Li JJ, Li SA, Daling JR (eds), Hormonal Carcinogenesis III (New York: Springer-Verlag), pp 471-476
48. Visscher PM, Thompson R, Haley CS (1996) Confidence intervals in QTL mapping by bootstrapping. Genetics 143:1013-1020
49. Wendell DL, Gorski J (1997) Quantitative trait loci for estrogen-dependent pituitary tumor growth in the rat. Mamm Genome 8:823-829
50. Wendell DL, Herman A, Gorski J (1996) Genetic separation of tumor growth and hemorrhagic phenotypes in an estrogen-induced tumor. Proc Natl Acad Sci U S A 93:8112-8116
51. Wendell DL, Daun SB, Stratton MB, Gorski J (2000) Different functions of QTL for estrogen-dependent tumor growth of the rat pituitary. Mamm Genome 11:855-861
52. Wendell DL, Pandey J, Kelley P (2002) A congenic strain of rat for investigation of control of estrogen-induced growth. Mamm Genome 13:664-666
53. Wiklund JA, Gorski J (1982) Genetic differences in estrogen-induced deoxyribonucleic acid synthesis in the rat pituitary: Correlations with pituitary tumor susceptibility. Endocrinology 111:1140-1149
54. Wiklund J, Rutledge J, Gorski J (1981a) A genetic model for the inheritance of pituitary tumor susceptibility in F344 rats. Endocrinology 109:1708-1714
55. Wiklund J, Wertz N, Gorski J (1981b) A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109:1700-1707
56. Wright S (1968) The genetics of quantitative variability. In: Evolution and the genetics of populations: genetics and biometrical foundations (Chicago, IL: University of Chicago Press), pp 373-420
57. Zeng ZB (1993) Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. Proc Natl Acad Sci U S A 90:10972-10976
58. Zeng ZB (1994) Precision mapping of quantitative trait loci. Genetics 136:1457-1468